The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Understanding the non-curative potential of palliative chemotherapy: Do patients hear what they want to hear?
 
Andrea Catherine Enzinger
Consulting or Advisory Role - Amgen (I); Five Prime Therapeutics (I); Merck (I); Pfizer (I); Sirtex Medical (I)
 
Jen Wind
No Relationships to Disclose
 
Elizabeth Frank
No Relationships to Disclose
 
Nadine Jackson McCleary
No Relationships to Disclose
 
Christine Cronin
No Relationships to Disclose
 
Hanna Kelly Sanoff
Research Funding - Bayer (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Precision Biologics (Inst)
 
Katherine Van Loon
No Relationships to Disclose
 
Khalid Matin
No Relationships to Disclose
 
Andrea J. Bullock
Stock and Other Ownership Interests - Amgen; Johnson & Johnson; Medtronic
Consulting or Advisory Role - Celgene; EMD Serono; Halozyme
 
Neal J. Meropol
Research Funding - Genomic Health
Patents, Royalties, Other Intellectual Property - US Patent (20020031515): Methods of therapy for cancers characterized by over expression of the HER2 receptor protein; US Patent Office “Systems and methods for matching patients with clinical trials.” (Cui, Mergler, Meropol, Tao, and Guo-Qiang Zhang). Patent pending, filed January 5, 2016. 14/988,132
 
Hajime Uno
Consulting or Advisory Role - ION Pharma
 
Deborah Schrag
Other Relationship - JAMA-Journal of the American Medical Association